Skip to main content

Lilly’s experimental weight-loss drug may be a ‘multibillion-dollar opportunity’

The company says tirzepatide can help people lose up to 22.5% of their body weight.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.